Trypanosome microtubule-associated protein p15 as a vaccine for the prevention of African sleeping sickness. (Q45953940)

18 December 2017

title

Trypanosome microtubule-associated protein p15 as a vaccine for the prevention of African sleeping sickness. (English)

1 reference

18 December 2017

main subject

African trypanosomiasis

1 reference

Reuven Rasooly

1 reference

18 December 2017

Naomi Balaban

series ordinal

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

18 December 2017

published in

Vaccine

1 reference

18 December 2017

volume

1 reference

18 December 2017

issue

1 reference

18 December 2017

page(s)

1007-1015

1 reference

18 December 2017

Vector-borne parasitic diseases--an overview of recent changes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Lessons learned from the emergence of a new Trypanosoma brucei rhodesiense sleeping sickness focus in Uganda.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Resurrecting the resurrection drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Treatment perspectives for human African trypanosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Tsetse eradication programme under fire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Tsetse control: the next 100 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Antigenic variation in African trypanosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Immune responses of cattle to African trypanosomes: protective or pathogenic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Partial protection against natural trypanosomiasis after vaccination with a flagellar pocket antigen from Trypanosoma brucei rhodesiense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Intracellular Antigens (Microtubule-Associated Protein Copurified with Glycosomal Enzymes)--Possible Vaccines against Trypanosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Molecular architecture of the trypanosome cytoskeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Isolation of a subpellicular microtubule protein from Trypanosoma brucei that mediates crosslinking of microtubules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

The repetitive microtubule-associated proteins MARP-1 and MARP-2 of Trypanosoma brucei.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Isolation and characterization of a unique 15 kilodalton trypanosome subpellicular microtubule-associated protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Structure of p15 trypanosome microtubule associated protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Immunization with a tubulin-rich preparation from Trypanosoma brucei confers broad protection against African trypanosomosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Immunization with recombinant paraflagellar rod protein induces protective immunity against Trypanosoma cruzi infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Trypanosoma brucei: anti-tubulin antibodies specifically inhibit trypanosome growth in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Induction of CD4+CD8+ double positive T cells and increase in CD5+ B cells in efferent lymph in sheep infected with Trypanosoma evansi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Activation of CD4+ and CD8+ parasite -specific T-cells by macrophages infected with live T. Cruzi amastigotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Different trypanozoan species possess CD8 dependent lymphocyte triggering factor-like activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

L-Arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

Nitric oxide synthesis is depressed in Bos indicus cattle infected with Trypanosoma congolense and Trypanosoma vivax and does not mediate T-cell suppression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.041

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.08.041

1 reference

18 December 2017

1 reference

18 December 2017